Evidence map›Paper›PMID 39886222›Full record

ArticleChemical & biomedical imaging2025

A Long Fluorescence Lifetime Probe for Labeling of Gram-Negative Bacteria.

Assel Baibek, Zuzanna Konieczna, Muhammed Üçüncü, Zainab S Alghamdi, Richa Sharma, Mathew H Horrocks, Mark Bradley

Abstract read
In one paragraph

Article in Chemical & biomedical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Assel BaibekSchool of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.ORCID https://orcid.org/0009-0000-0027-3883
Zuzanna KoniecznaSchool of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
Muhammed ÜçüncüDepartment of Analytical Chemistry, Faculty of Pharmacy, İzmir Katip Çelebi University, 35620 İzmir, Turkey.ORCID https://orcid.org/0000-0001-6200-9340
Zainab S AlghamdiDepartment of Chemistry, College of Science, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.ORCID https://orcid.org/0009-0006-8926-162X
Richa SharmaSchool of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.ORCID https://orcid.org/0000-0003-1567-1176
Mathew H HorrocksSchool of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.ORCID https://orcid.org/0000-0001-5495-5492
Mark BradleyPrecision Healthcare University Research Institute, Queen Mary University of London, Whitechapel, London E1 4NS, United Kingdom.ORCID https://orcid.org/0000-0001-7893-1575

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial resistance, primarily stemming from misdiagnosis, misuse, and overuse of antibacterial medications in humans and animals, is a pressing issue. To address this, we focused on developing a fluorescent probe for the detection of bacteria, with a unique feature-an exceptionally long fluorescence lifetime, to overcome autofluorescence limitations in biological samples. The polymyxin-based probe (ADOTA-PMX) selectively targets Gram-negative bacteria and used the red-emitting fluorophore azadioxatriangulenium (with a reported fluorescence lifetime of 19.5 ns). Evaluation of ADOTA-PMX's bacterial labeling efficacy revealed strong specificity for Gram-negative bacteria, and full spectral fluorescence lifetime imaging microscopy demonstrated the potential of ADOTA-PMX for bacterial imaging applications. The probe exhibited a lifetime of 4.5 ns when bound to bacteria, possibly indicating interactions with the bacterial outer membrane. Furthermore, the fluorescence lifetime measurements of ADOTA-PMX labeled bacteria could be performed using a benchtop fluorimeter without the need of sophisticated microscopes. This study represents the first targeted probe for fluorescence lifetime imaging, offering sensitivity for detecting Gram-negative bacteria and enabling multiplexing via fluorescence lifetime imaging.

Identifiers

PMID39886222
PMCPMC11775855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.